chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child presented with 102 degree temp on 08/11/06 pm.  Awakened on Sat, 08/12/06 with 102 - 103 temp and facial swelling and numbness, hurting severely in joints, and tired.  Collapsed on sofa stating he was so tired and hurting and could not feel his cheeks, also felt like he had a baseball in his throat.  I immediately gave hime Benadryl and Tylenol.  I called my pediatrician's office and spoke to the physician on call. He recommended the Benadryl and if symptoms progressed any, to call him and bring him to the ER.
Narrative:  Pt was an 88 YO male with PMH of tremor, hypothyroidism, seborrheic dermatitis, arthritis, allergic rhinitis, sleep apnea, HLD, CAD, HTN, and bradycardia. Pt received Moderna COVID-19 vaccine on 1/21/21 and 2/19/21. Death was reported by facility: no additional details provided. Death does not appear to be related to COVID-19 vaccine.
Three days after the shot i had a fever of 103 and started vomiting and had flu like symptoms for several days and have never recovered and have been sick to my stomach and vomiting ever since and have been dry heaving every day.  And my heart rate is over 100 and climbs to over 130 with any motion
Patient see in ED 4/22/2021 for evaluation of severe, constant throat swelling starting earlier today after receiving her first COVID-19 vaccine. The patient was well until roughly ten to fifteen minutes after receiving her first dose of a COVID-19 vaccine at 1158. She gradually developed severe throat swelling, tongue swelling, and itching to her uvula and back of her throat, as well as a change in her voice. The patient was immediately given 0.5 IM epinephrine at the clinic and was given two dose of 25 mg benadryl en route by EMS. Symptoms improved after epinephrine and benadryl. Patient was discharged from ED against medical advice and returned to ED around 2100 for reported back of tongue swelling, swollen uvula, and "scratchy voice". Patient was then admitted to hospital for observation.
The patient had received both injections in the original series and presented for a booster. The booster was given and the nurse realized after that she had mis-read the date of the second dose in the series and instead of being 6/7/21 it was actually 6/7/22. So the booster should not have been administered.
Large grapefruit-size fluid filled cystic lesion (L) deltoid I aspirated 30 cc of clear yellow joint fluid.
Patient made an appointment on website for his 2nd Pfizer vaccine. Arrived to pharmacy with school-appointed guardian and received his 2nd Pfizer dose. Insurance was not received and run until patient arrived at the pharmacy and rejected citing dose "too soon." Per CAIR registry, first dose was 10/18/21 only 7 days before the 2nd was given. Pfizer 2nd dose should be given 21 days after the first dose.
48 hours of fever, severe headache and aches. Swollen and painful limphknots in armpit.
He woke up the next day after the vaccine he did not know where he was and was confused.  He did not take his medications, did not remember to take it.  He came out to his wife and she heard some noise and he looked over to the dog dish to refill it and didn't refill it as he usually does.  Just a lot of forgetful things that he did.  He had dizziness and was hanging on the door frame and went to bed, and told his wife that he did not know anything and did not know what he was doing.  They took him to the doctor and was seen by the doctor who checked his VS and said that he was okay, and told them that he was having a reaction to the vaccine, and was starting to come around and remembering things while he was in the doctors office.  They were advised to take him home and let him rest, and he did and didn't eat until last evening.  He had the same reaction that he had when he had the COVID virus.  He knew everything this morning and back to his baseline.
A non-serious spontaneous report of coughing, wheezing, and fever has been received from a physician concerning an eight-year-old female, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received FLUMIST on 14-Oct-2009. On 16-Oct-2009, the patient experienced coughing, wheezing, and fever. No outcome was reported for the event of coughing, wheezing, and fever.
Dizziness, Myalgia, Arthralgia, chills, mental fog, achey, fatigue Narrative: After 2nd dose of covid vaccine pt experienced the following side effects: myalgia, arthralgia,chills, dizzy, mental fog, achey & fatigue.  Pt took 400mg ibuprofen oral for relief.
Fever for a week up to 104 at one point, chills, body aches, pain on entire left side of body, lump and rash at the site of injection, loss of consciousness and seizure. Went to hospital and released same day. Continued with rest, Advil and Tylenol and was better a week later.
Patient came in requesting Janssen Covid-19 vaccination in the early afternoon on Thursday 10/28/2021. Patient contacted the pharmacy the following day (Friday 10/29/2021) stating he started having ear ringing around 4pm after receiving his vaccine. I asked patient if he had tried anything to alleviate the ringing. Patient stated he did not try anything yet. I instructed patient to drink lots of fluids to stay hydrated and if ear ringing persisted, contact his primary doctor to follow up.
Moderate size hive over injection site on right arm where I received the vaccine.  This didn?t start until March 10. Over a week after I received the vaccine. It is extremely itchy. It is  also raised and red.
Patient said 16 days later, has entire arm from elbow up  painful but bruise to where it looks black.
No additional adverse effect reported.; GARDASIL 9 that underwent a temperature excursion was administered.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided.  On 01-APR-2021, the patient was vaccinated with an improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot # T024831 was confirmed to be valid, expiration date 18-NOV-2022, (dose, route and site of administration were not reported) for prophylaxis. The administered dose was exposed to the temperature from 47 degrees Fahrenheit (F) to 77 F (46.6 F) for 42 minutes. There was no previous temperature excursion. The call was because of a digital data logger. No additional adverse effect was reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T024831; expirationdate: 18-NOV-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2104USA001895: US-009507513-2104USA001892: US-009507513-2104USA001897:
Immediately after immunizations given, pt began c/o ABD pain and back pain. Went to bathroom then began vomiting repetitively and has stool incontinence. C/O lips and hands "hurting". Lips slightly swollen, cold, hands purplish.
First dose administered to 12 year old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to 12 year old) in a 12-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to 12 year old). On 10-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to 12 year old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
A report has been received from a pharmacist concerning a 42 year old, female subject, who had been receiving FLUMIST QUADRIVALWNT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 12-Sep-2014. Pharmacist reported patient believed she received more of the FLUMIST in one nostril that the other which started on 12-Sep-2014. The outcome of the event of patient said she got more of the FLUMIST in one nostril than the other is unknown. The report was considered to be non-serious by the reporter.
Developed a hive like rash, redness of skin with bumpy texture around both armpits. Affected area feel warm to touch, itchy and painful at times.
This spontaneous report was received from a registered nurse refers to an unspecified patients of unknown age and gender. Since 17-FEB-2015, the patients were vaccinated with GARDASIL (strength, dose, lot# were not reported) intramuscular which were stored improperly. No Product Quality Complaint (PQC) was involved. This is one of the several reports from the same source. Additional information has been requested.
Information received by a registered nurse concerning pt with reaction at injection site, crying, pain at injection site. Pt experienced similar reaction post other vaccine's.
Subsequently the pt experienced whole body arthralgias. A doctor visit was required. The reporter stated that there was no swelling or warmth at the joints. It was unknown if joint fluid was obtained. As of 2/15/01, the outcome of the event is unknown.
Pt given Moderna booster (0.25ml) less than 6 months after initial series.
Woke up after 12 hours of receiving 2nd moderna does with fever and chills. The fever was around 99.4 but spiked up to 101. I received the 2nd does on a Friday and fever spike Saturday night. It is Sunday and still tired but no fever.
Body aches; Headache; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea). On 22-Feb-2021, PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) had resolved.            No relevant concomitant medications were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Outcome of the events updated. Duration of the event added as 5 days.
Patient became dizzy and disoriented aprox 3 minutes after shot. ems help refused pt fully recovered after 30 minutes
had neck pain prior to receipt of the first dose of the vaccine, but it persisted and became worse after getting the vaccine; had neck pain prior to receipt of the first dose of the vaccine, but it persisted and became worse after getting the vaccine; This is a spontaneous report from a contactable physician (reporting for himself).  A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 08Jan2021 at a single dose for COVID-19 immunization.  Medical history included neck soreness/neck pain (takes a Medrol dose pack for neck pain, reporting a history of neck soreness occasionally).  The patient's concomitant medications were not reported.  In Jan2021, the patient reported that he had neck pain prior to receipt of the first dose of the vaccine, but it persisted and became worse after getting the vaccine.  The outcome of the events was unknown.    The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Ocular Myasthenia Gravis. Adverse events: Severe, disabling diplopia, 4th nerve palsy in right eye, drooping eyelids alternately in both eyes, raised eyebrow over left eye.  Treatment: immune system suppressant Prednisone 40 mg daily for one month. Treatment was ineffective.  Outcome: Myasthenia Gravis is a permanent, incurable, degenerative, auto-immune disease. Ocular Myasthenia Gravis precedes severely disabling generalized Myasthenia Gravis in 85% of ocular instances.
patient developed aches, chills and headache 12 hours post vaccine.  Symptoms resolved within 24-48 hours
Tingling down my arm; Sensation like pricking needle; Tingling numbness in left front section of my head; Progressed in left side my face; Sort of numbness not feeling anything lasted several hrs or half a day; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling down my arm), PARAESTHESIA (Sensation like pricking needle), HYPOAESTHESIA (Tingling numbness in left front section of my head), PARAESTHESIA (Progressed in left side my face) and HYPOAESTHESIA (Sort of numbness not feeling anything lasted several hrs or half a day) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included Tingling and Numbness.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PARAESTHESIA (Tingling down my arm), PARAESTHESIA (Sensation like pricking needle), HYPOAESTHESIA (Tingling numbness in left front section of my head), PARAESTHESIA (Progressed in left side my face) and HYPOAESTHESIA (Sort of numbness not feeling anything lasted several hrs or half a day). On 03-Mar-2021, PARAESTHESIA (Tingling down my arm), PARAESTHESIA (Sensation like pricking needle), HYPOAESTHESIA (Tingling numbness in left front section of my head), PARAESTHESIA (Progressed in left side my face) and HYPOAESTHESIA (Sort of numbness not feeling anything lasted several hrs or half a day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information were not provided by the reporter. Treatment information were not provided by the reporter.
Redness, induration, just below deltoid area L arm began 24 hrs after injections of influenza & pneumonia vaccine.  Achey &  aneretis at onset, + 48 hrs area of redness warm & mildly tender at onset.
Left deltoid with redness, swelling, warmth, 8x6cm, instructed to apply warm compress 3-4 times daily and to call for appointment if fever or worsening symptoms occur within 24 hours.
Took flu vaccine about 220 pm on 12/3/09, returned at 340p complained of slight dizziness, "tightness in throat that came and went" T 99 P 80 R 16 B/P 130/80. Given BENADRYL 125 mg PO. Observed x 45 min. 410P 118/80 P 60 R 15 425 p 116/78 P 68 R 16 Denies wheezing SOB. States feels ok.
Scattered non-puritic papules that are urticaria-like. No other systemic involvement. Pt had same rash in January after 1st IPV on 01/16/2002.
Eyes tingling; Tired; Headache; Lip tingling; Tip of nose tingling; made her nervous.; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Lip tingling), PARAESTHESIA (Tip of nose tingling), NERVOUSNESS (made her nervous.), PARAESTHESIA (Eyes tingling) and FATIGUE (Tired) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PARAESTHESIA ORAL (Lip tingling), PARAESTHESIA (Tip of nose tingling), NERVOUSNESS (made her nervous.), FATIGUE (Tired) and HEADACHE (Headache). On an unknown date, the patient experienced PARAESTHESIA (Eyes tingling). At the time of the report, PARAESTHESIA ORAL (Lip tingling), PARAESTHESIA (Tip of nose tingling), NERVOUSNESS (made her nervous.), PARAESTHESIA (Eyes tingling), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
102 degree fever, headache, loss of appetite, and tiredness.  Treated with Tylenol to reduce fever.  Fever and other symptoms stopped after 48 hours.  Called nurse on 8/25/06 and they said they did not think it was because of the vaccine, that she may have picked up another illness while in the office.
Parotid Salivary Gland Infection (left side) - swollen left side of mouth with fever up to 101 deg C.  Patient developed fever around 3 pm on 06/24 and woke up 06/25 with  significant swelling of left side of the mouth Took patient to doctor office on 06/25/21 morning to see the Dr who was on call. Dr put him on antibiotic amoxicillin
12 hours I was at home and had another seizure just as before on my first dose. I was taken to the ER after my fiancé found me again.
Large, hot, hard and red swelling at site of injection, palm-sized. Still lasting 2 days after injection. Fatigue, wooziness, inability to work for at least two days. Systemic affects unlike any other vaccine reaction writer has had, and writer has gotten allergy shots for over 20 years.
immune deficiency problem after booster; bad issue after booster; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNODEFICIENCY (immune deficiency problem after booster) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNODEFICIENCY (immune deficiency problem after booster) (seriousness criterion medically significant) and IMMUNISATION REACTION (bad issue after booster). At the time of the report, IMMUNODEFICIENCY (immune deficiency problem after booster) and IMMUNISATION REACTION (bad issue after booster) outcome was unknown.            No concomitant medication reported. No treatment medication details reported.
No additional AE's and no PQC's were reported; The nurse stated that improperly stored vaccines were administered to patients.     ?; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported.   On 11-APR-2022, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live Albumin status rHA (recombinant Human albumin) (PROQUAD) lot# U022724, expiration date reported as 16-JAN-2023, use as directed to prevent measles, mumps, rubella and varicella infection (prophylaxis) (strength, dose, route and frequency were not reported) (product storage error).   The temperature excursion was of 7.5 Fahrenheit degrees (°F), during 15 minutes. A previous temperature excursion was not reported. No additional adverse event and no PQC's were reported.
The vaccine was administered Sub-Q instead of IM. Spoke to pt she is fine no adverse Reaction.
No adverse effects noted at this time; patient, 5 days old, inadvertently received a dose of ROTATEQ that was selected instead of another unspecified vaccine; patient, 5 days old, inadvertently received a dose of ROTATEQ that was selected instead of another unspecified vaccine; This spontaneous report was received from a medical assistant referring to a 5 day old patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.     On 20-JUN-2019, the patient inadvertently received a dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) by oral route, lot # R026541, expiry date on 11-JUL-2020, for prophylaxis; that was selected instead of another unspecified vaccine. No treatment was needed to be given. Patient was presently with parents in office and no adverse effects were noted.
Pain in stomach, & hip area on the day of injection accompanied by chills & fever, nausea, vomiting & diarrhea.  the following day had blood blisters in her mouth and face and had scattered petechiae.  Saw her allergist on 10/17/19.  Blood work done.  Was called on 10/18/19 to go to the ED due to dangerously low platelets.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Weakness-Medium, Additional Details: All vitals were stable; eyes were responsive to light; blood sugar also when checked was stable; we called EMT and they aslo checked her vitals and still everything was within normal limits. She was taken to hospital by ambulance for more observation.
He initially began with numbness and pain in his hands around 6pm and it progressed to his arms by the following day. By 10/11/2013 he began with hip pain that continued to descend to feet throughout the day.  By Saturday morning around 7 am on 10/12/2013 he began with numbness.  He presented to hospital that am.  By the time he was discharged around 2pm he could no longer ambulate.  This progressed as the night went on.  His blood pressure was high at hosp. Like 200/90.  He had MRI completed and Xrays at this hospital.  By 3pm the decision was made to take him to yet another emergency room . He went to stand and began falling backwards, but was caught.  Around 630 pm on sat 10/12 he was taken into another hospital.  He could not stand, his pressure was 70/40's, he was not mentating appropriately.  He was triaged immediately when he began shaking and unable to communicate.  See hospital records for details that follow.  He was admitted to hospital at this point.  By Sunday around 6pm a lumbar puncture performed to obtain spinal fluid.  by Monday am, a confirmed diagnosis was given of Guillain Barre.  Plan then was to begin IVIG treatments x 5.  This was performed and patient was eventually transferred to rehab by Sat 10/19.
Information has been received from a Medical Assistant concerning an approximately 66 year old female with no known allergies who on an unspecified date was vaccinated with 0.65mL zoster vaccine live (Oka/Merck). Subsequently, the patient developed redness and soreness at the injection site after receiving the vaccination. Unspecified medical attention was sought. There were no lab studies performed. At the time of the report the patient had not recovered. There was no product quality complaint involved. Follow-up information has been received from a health care professional concerning this 65 year old female consumer who on 21-FEB-2008 was vaccinated SQ in the left arm with zoster vaccine live (Oka/Merck) (lot # 658861/1822U). Subsequently, on 21-FEB-2008 the patient experienced redness and soreness at the injection site after receiving the vaccine. It was to the point that the patient was not able to touch it. This lasted for seven days. The patient recovered on 28-FEB-2008. Additional information is not expected.